Philip R. Dormitzer
- Infectious Diseases top 0.2%
- Viral gastroenteritis research and epidemiology 33
- SARS-CoV-2 and COVID-19 Research 10
- Structural Biology top 1%
- Animal Science and Zoology top 0.2%
- Animal Virus Infections Studies 15
- Epidemiology top 1%
- Respiratory viral infections research 30
- Influenza Virus Research Studies 22
- Pneumonia and Respiratory Infections 10
- Immunology top 2%
-
- Virus-based gene therapy research 13
-
- Viral Infections and Immunology Research 7
- Co-authors
- Stephen C. HarrisonRino RappuoliEthan C. SettembreHarry B. GreenbergNikolaus GrigorieffKena A. SwansonShane D. TraskJeffrey B. Ulmer
- Journals
- Journal of Virology (13 papers)Vaccine (11 papers)Proceedings of the National Academy of Sciences (6 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Philip R. Dormitzer
78 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Infectious Diseases 3.7k
- Structural Biology 229
- Animal Science and Zoology 1.2k
- Epidemiology 2.1k
- Immunology 946
Countries citing papers authored by Philip R. Dormitzer
This map shows the geographic impact of Philip R. Dormitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Dormitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Dormitzer more than expected).
Fields of papers citing papers by Philip R. Dormitzer
This network shows the impact of papers produced by Philip R. Dormitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Dormitzer. The network helps show where Philip R. Dormitzer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip R. Dormitzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 31 | |
| 5 | Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited serabreakdown → | 2021 | 383 |
| 6 | BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variantsbreakdown → | 2021 | 212 |
| 7 | 2021 | 29 | |
| 8 | 2021 | 62 | |
| 9 | Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human serabreakdown → | 2021 | 333 |
| 10 | 2021 | 4 | |
| 11 | 2014 | 37 | |
| 12 | 2011 | 211 | |
| 13 | 2010 | 1 | |
| 14 | 2009 | 117 | |
| 15 | 2009 | 207 | |
| 16 | 2009 | 0 | |
| 17 | 2008 | 288 | |
| 18 | 2005 | 289 | |
| 19 | 2004 | 177 | |
| 20 | 1992 | 37 |
About Philip R. Dormitzer
Philip R. Dormitzer is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology, having authored 82 papers that have together received 6.5k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (33 papers), Respiratory viral infections research (30 papers), Influenza Virus Research Studies (22 papers), Animal Virus Infections Studies (15 papers), Virus-based gene therapy research (13 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Pneumonia and Respiratory Infections (10 papers) and Viral Infections and Immunology Research (7 papers). The work is most often cited by research in Infectious Diseases (3.7k citations), Structural Biology (229 citations) and Animal Science and Zoology (1.2k citations). Philip R. Dormitzer has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Stephen C. Harrison, Rino Rappuoli, Ethan C. Settembre, Harry B. Greenberg, Nikolaus Grigorieff, Kena A. Swanson, Shane D. Trask, Jeffrey B. Ulmer, Christian W. Mandl and Christine A. Shaw. Their work appears in journals such as Journal of Virology, Vaccine, Proceedings of the National Academy of Sciences, The Journal of Infectious Diseases and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.